Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

NCT00423696 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

145

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

BIOLOGICAL: bevacizumab
DRUG: capecitabine
DRUG: fluorouracil
DRUG: irinotecan hydrochloride
DRUG: leucovorin calcium

Sponsor

UNICANCER